Cargando…

Prognostic value of baseline metabolic tumour volume in advanced-stage Hodgkin’s lymphoma

Our aim was to evaluate the prognostic value of initial total metabolic tumour volume (TMTV) in a population of patients with advanced-stage Hodgkin’s lymphoma (HL). We retrospectively included 179 patients with stage IIb-III-IV Hodgkin’s disease who received BEACOPP or ABVD as the first-line treatm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pinochet, Pierre, Texte, Edgar, Stamatoullas-Bastard, Aspasia, Vera, Pierre, Mihailescu, Sorina-Dana, Becker, Stéphanie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636481/ https://www.ncbi.nlm.nih.gov/pubmed/34853386 http://dx.doi.org/10.1038/s41598-021-02734-w

Ejemplares similares

Reproducibility of Baseline Tumour Metabolic Volume Measurements in Diffuse Large B-Cell Lymphoma: Is There a Superior Method?
por: Eude, Florian, et al.
Publicado: (2021)

Correlations between baseline (18)F-FDG PET tumour parameters and circulating DNA in diffuse large B cell lymphoma and Hodgkin lymphoma
por: Decazes, Pierre, et al.
Publicado: (2020)

Infradiaphragmatic Hodgkin lymphoma: a large series of patients staged with PET-CT
por: Rossi, Cédric, et al.
Publicado: (2017)

High-risk stage IIB Hodgkin lymphoma treated in the H10 and AHL2011 trials: total metabolic tumor volume is a useful risk factor to stratify patients at baseline
por: Rossi, Cédric, et al.
Publicado: (2022)

Prognostic value of post-induction chemotherapy (18)F-FDG PET-CT in stage II/III non-small cell lung cancer before (chemo-) radiation
por: Ganem, Julien, et al.
Publicado: (2019)

Patient and physician preferences for first‐line treatment of classical Hodgkin lymphoma in Germany, France and the United Kingdom
por: Bröckelmann, Paul J., et al.
Publicado: (2018)

Targeted genotyping of circulating tumor DNA for classical Hodgkin lymphoma monitoring: a prospective study
por: Camus, Vincent, et al.
Publicado: (2020)

Fatigue level changes with time in long-term Hodgkin and non-Hodgkin lymphoma survivors: a joint EORTC-LYSA cross-sectional study
por: Busson, Raphaël, et al.
Publicado: (2019)

Predictive value of baseline metabolic tumor volume in early-stage favorable Hodgkin Lymphoma – Data from the prospective, multicenter phase III HD16 trial
por: van Heek, Lutz, et al.
Publicado: (2022)

P024: Predictive Value of Baseline Metabolic Tumor Volume in Early-Stage Favorable Hodgkin Lymphoma – Data from the Prospective, Multicenter Phase III HD16 Trial
por: Van Heek, Lutz, et al.
Publicado: (2022)

Prognostic value of baseline total metabolic tumour volume of (18)F-FDG PET/CT imaging in patients with angioimmunoblastic T-cell lymphoma
por: Gong, Huanyu, et al.
Publicado: (2021)

Prognostic value of combined MTV and ADC derived from baseline FDG PET/MRI in aggressive non-Hodgkins lymphoma
por: Husby, Trine, et al.
Publicado: (2022)

Defining the optimal method for measuring baseline metabolic tumour volume in diffuse large B cell lymphoma
por: Ilyas, Hajira, et al.
Publicado: (2018)

Impact of Provider Volume on Outcomes of Patients With Hodgkin Lymphoma
por: Ireland, Catherine, et al.
Publicado: (2018)

Prognostic value of sarcopenia in patients treated by Radiochemotherapy for locally advanced oesophageal cancer
por: Mallet, Romain, et al.
Publicado: (2020)

Prognostic Markers within the Tumour Microenvironment in Classical Hodgkin Lymphoma
por: Martynchyk, Arina, et al.
Publicado: (2023)

Non-Hodgkin's Lymphoma Reversal with Dichloroacetate
por: Flavin, Dana F.
Publicado: (2010)

Prognostic Impact of Baseline Immunologic Profile in Aggressive B-cell non-Hodgkin’s Lymphomas
por: Ramadan, Safaa, et al.
Publicado: (2021)

Impact of the Bayesian penalized likelihood algorithm (Q.Clear®) in comparison with the OSEM reconstruction on low contrast PET hypoxic images
por: Texte, Edgar, et al.
Publicado: (2020)

Proliferation in Non-Hodgkin’S Lymphomas and Its Prognostic Value Related to Staging Parameters
por: Lorand‐Metze, Irene, et al.
Publicado: (2004)

Prevalence of Common Non-Hodgkin Lymphomas and Subtypes of Hodgkin Lymphoma by Nodal Site of Involvement: A Systematic Retrospective Review of 938 Cases
por: Laurent, Camille, et al.
Publicado: (2015)

A phase II study of the oral JAK1/JAK2 inhibitor ruxolitinib in advanced relapsed/refractory Hodgkin lymphoma
por: Van Den Neste, Eric, et al.
Publicado: (2018)

Deoxythymidine kinase in the tumour cells and serum of patients with non-Hodgkin lymphomas.
por: Rehn, S., et al.
Publicado: (1995)

Influence of Software Tool and Methodological Aspects of Total Metabolic Tumor Volume Calculation on Baseline [18F]FDG PET to Predict Survival in Hodgkin Lymphoma
por: Kanoun, Salim, et al.
Publicado: (2015)

P017: The role of baseline bulk and dissemination measures as predictors of progression in advanced Hodgkin lymphoma
por: Taszner, Michal, et al.
Publicado: (2022)

Managing advanced stage Hodgkin lymphoma
por: Saikia, TK
Publicado: (2015)

Diagnostic value of baseline (18)FDG PET/CT skeletal textural features in follicular lymphoma
por: Faudemer, Julie, et al.
Publicado: (2021)

Prognostic value of baseline metabolic tumor volume and total lesion glycolysis in patients with lymphoma: A meta-analysis
por: Guo, Baoping, et al.
Publicado: (2019)

On the Added Value of Baseline FDG-PET in Malignant Lymphoma
por: Quarles van Ufford, Henriette, et al.
Publicado: (2009)

Dual Immunotherapy Adds Value in Relapsed/Refractory Hodgkin Lymphoma
por: Hallam, Simon
Publicado: (2018)

T057: Circulating tumor DNA in classical Hodgkin lymphoma patients treated with pembrolizumab and chemotherapy: dynamic response assessment and correlation with baseline total metabolic tumor volume
por: Lynch, Ryan C., et al.
Publicado: (2022)

Primary Pulmonary Hodgkin Lymphoma Simulating a Mediastinal Tumour: an Uncommon Occurrence
por: Fratoni, Stefano, et al.
Publicado: (2013)

Importance of baseline PET/CT imaging on radiation field design and relapse rates in patients with Hodgkin lymphoma
por: Figura, Nick, et al.
Publicado: (2017)

Radiation Therapy for Advanced-Stage Hodgkin Lymphoma
por: Lockney, Natalie A., et al.
Publicado: (2020)

Advanced stage Hodgkin Lymphoma: patient management
por: Gini, Guido, et al.
Publicado: (2020)

Peripheral T Cell Non-Hodgkin's Lymphoma following Treatment of Hodgkin's Lymphoma
por: Chang, Sun Hee, et al.
Publicado: (2015)

Recent advances in the first-line treatment of follicular non-Hodgkin lymphoma
por: Feugier, Pierre, et al.
Publicado: (2019)

Healthy Organs Uptake on Baseline (18)F-FDG PET/CT as an Alternative to Total Metabolic Tumor Volume to Predict Event-Free Survival in Classical Hodgkin's Lymphoma
por: Morland, David, et al.
Publicado: (2022)

Concomitant occurrence of genetically distinct Hodgkin lymphoma and primary mediastinal lymphoma
por: Dubois, Sydney, et al.
Publicado: (2021)

Comparison of different automatic methods for the delineation of the total metabolic tumor volume in I–II stage Hodgkin Lymphoma
por: Martín-Saladich, Queralt, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kq9foj3lg8vnllj0vqk7bt9abb